Pemetrexed and Imjudo drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Pemetrexed (pemetrexed) and Imjudo (tremelimumab-actl). Common drug interactions include dermatitis among females and rash among males.
The phase IV clinical study analyzes what interactions people have when they take Pemetrexed and Imjudo. It is created by eHealthMe based on reports of 35 people who take the same drugs from the FDA, and is updated regularly.
What is Pemetrexed?
Pemetrexed has active ingredients of pemetrexed. eHealthMe is studying from 17,491 Pemetrexed users. Check the latest studies of Pemetrexed.
What is Imjudo?
Imjudo has active ingredients of tremelimumab-actl. eHealthMe is studying from 643 Imjudo users. Check the latest studies of Imjudo.
35 people who take Pemetrexed and Imjudo together, and have interactions are studied.
What are the common drug interactions of Pemetrexed and Imjudo, by gender? *:
female:
- Dermatitis (inflammation of the skin resulting from direct irritation by an external agent or an allergic reaction to it)
- Drug eruption (adverse drug reaction of the skin)
- Erythema multiforme (a type of hypersensitivity reaction)
- Pruritus (severe itching of the skin)
- Rash
- Skin disorder (skin disease)
male:
- Rash
- Nausea (feeling of having an urge to vomit)
- Neutropenia (an abnormally low number of neutrophils)
- Diarrhoea
- Neutrophil count decreased (less than normal number of neutrophil a type of blood cell)
- Anaphylactic reaction (serious allergic reaction)
- Bacterial infection
- Cardiac failure
- Hiccups (an involuntary spasm of the diaphragm and respiratory organs, with a sudden closure of the glottis and a sound like a cough)
- Liver disorder (liver diseases)
What are the common drug interactions of Pemetrexed and Imjudo, by age (0-1 to 60+)? *:
0-1:
n/a
2-9:
n/a
10-19:
n/a
20-29:
n/a
30-39:
n/a
40-49:
n/a
50-59:
- Nausea (feeling of having an urge to vomit)
- Pyrexia (fever)
- Rash
- Anaphylactic reaction (serious allergic reaction)
- Decreased appetite
- Metastases to lung (cancer spreads to lung)
- Neutropenia (an abnormally low number of neutrophils)
- Pancreatic enlargement
- Abdominal pain upper
- Diabetes mellitus (diabetes, caused by a deficiency of the pancreatic hormone insulin)
60+:
- Rash
- Platelet count decreased
- Liver disorder (liver diseases)
- Nausea (feeling of having an urge to vomit)
- Pyrexia (fever)
- Renal impairment (severely reduced kidney function)
- Rhabdomyolysis (a condition in which damaged skeletal muscle tissue breaks down)
- Skin disorder (skin disease)
- Cardiac failure acute
- Hypersensitivity
What are the existing conditions these people have? *
- Lung Cancer - Non-Small Cell (lung cancer): 35 people, 100.00%
* Approximation only. Some reports may have incomplete information.
Do you take Pemetrexed and Imjudo?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
- Pemetrexed (17,491 reports)
- Imjudo (643 reports)
Browse all drug interactions of Pemetrexed and Imjudo:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Pemetrexed:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Imjudo:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Pemetrexed and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Imjudo and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Gota V, Kavathiya K, Doshi K, Gurjar M, Damodaran SE, Noronha V, Joshi A, Prabhash K, "High plasma exposure to pemetrexed leads to severe hyponatremia in patients with advanced non small cell lung cancer receiving pemetrexed-platinum doublet chemotherapy", Cancer management and research, 2017 Jan .
- Gota V, Kavathiya K, Doshi K, Gurjar M, Damodaran SE, Noronha V, Joshi A, Prabhash K, "High plasma exposure to pemetrexed leads to severe hyponatremia in patients with advanced non small cell lung cancer receiving pemetrexed-platinum doublet chemotherapy", Cancer management and research, 2017 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on pemetrexed and tremelimumab-actl (the active ingredients of Pemetrexed and Imjudo, respectively), and Pemetrexed and Imjudo (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Drug interactions of Aciphex and Oxybutynin Chloride - 8 seconds ago
- Could Amisulpride cause Sinus Tachycardia? - 10 seconds ago
- Could Sutent cause Hypogeusia? - 11 seconds ago
- Could Lovenox cause Glucose Tolerance Impaired? - 19 seconds ago
- Could Golytely cause Drug Hypersensitivity? - 22 seconds ago
- Drug interactions of Glucophage Xr and Dyazide - 26 seconds ago
- Could Ocaliva cause Malaise? - 32 seconds ago
- Drug interactions of Levetiracetam and Flovent Hfa - 34 seconds ago
- Could Ibu cause Pharyngeal Disorder? - 36 seconds ago
- Could Bisoprolol Fumarate cause Pulmonary Arterial Pressure Increased? - 38 seconds ago